| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 09/07/2024 | 13h30 | GlobeNewswire Inc. | Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 30/05/2024 | 15h12 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 24/05/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 24/05/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 22h49 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 16h21 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 02h13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 02h12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 02h05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 02h03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 21/05/2024 | 02h02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h53 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h52 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h51 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h50 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h50 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h49 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h49 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h48 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h47 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h47 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h46 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h45 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h45 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h44 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h42 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h41 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 20/05/2024 | 14h38 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALPN | Alpine Immune Sciences Inc |